Login/Sign Up
₹445.5*
MRP ₹495
10% off
₹420.75*
MRP ₹495
15% CB
₹74.25 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Therapeutic Class
Country of origin
We provide you with authentic, trustworthy and relevant information
Mirahype S 50/5 Tablet ER contains Solifenacin and Mirabegron. Solifenacin reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. This decreases the urgency for urination. Mirabegron relaxes the muscles of the bladder; this prevents frequent, uncontrolled, or urgent urination. Together, Mirahype S 50/5 Tablet ER helps in treating an overactive bladder.
There is some overlap between the symptoms of both OAB and BPH. OAB occurs due to uncontrolled urinary bladder muscle contractions. The main symptom of OAB is a sudden urge to urinate that's hard to control, which is stressful. On the other hand, BPH occurs due to an enlarged prostate gland, which puts pressure on the urinary bladder, thereby causing pain during urination.
Dry mouth could be a side effect of Mirahype S 50/5 Tablet ER. Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol; drinking water regularly, and chewing sugar-free gum/candy might stimulate saliva and prevent drying of the mouth.
Mirahype S 50/5 Tablet ER might cause hypertension. Therefore, consult your doctor before taking Mirahype S 50/5 Tablet ER if you have high blood pressure.
Constipation could be a side-effect of Mirahype S 50/5 Tablet ER. Eat fibre-rich food and drink plenty of fluids if you experience constipation. Talk to your doctor if you have severe constipation.
Alcohol
Caution
You are recommended to avoid or limit alcohol consumption while taking Mirahype S 50/5 Tablet ER as it may cause increased dizziness.
Pregnancy
Caution
Limited information is available regarding the usage of Mirahype S 50/5 Tablet ER during pregnancy. Consult your doctor before taking Mirahype S 50/5 Tablet ER if you are pregnant.
Breast Feeding
Caution
Limited information is available regarding the usage of Mirahype S 50/5 Tablet ER during breastfeeding. Consult your doctor before taking Mirahype S 50/5 Tablet ER if you are breastfeeding.
Driving
Caution
Mirahype S 50/5 Tablet ER may cause blurred vision and tiredness. Drive or operate machinery only if you are alert.
Liver
Caution
Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Caution
Mirahype S 50/5 Tablet ER is not recommended for children as safety and effectiveness have not been established.
About Mirahype S 50/5 Tablet ER
Mirahype S 50/5 Tablet ER is a combination medicine used to treat overactive bladder (OAB) with symptoms of urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, and dysuria (painful or difficult urination). Overactive bladder is a condition in which there is a problem with bladder function, which causes a sudden urge to urinate that might be difficult to control.
Mirahype S 50/5 Tablet ER contains Solifenacin (anti-cholinergic) and Mirabegron (beta-3 adrenergic agonist). Solifenacin reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. This decreases the urgency for urination. Mirabegron relaxes the muscles of the bladder; this prevents frequent, uncontrolled, or urgent urination. Together, Mirahype S 50/5 Tablet ER helps in treating overactive bladder.
You are advised to take Mirahype S 50/5 Tablet ER for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience common side-effects such as dry mouth, constipation, headache, high blood pressure, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor if you are pregnant or breastfeeding. Mirahype S 50/5 Tablet ER is not recommended for children as safety and efficacy have not been established. Mirahype S 50/5 Tablet ER may cause blurred vision, so drive with caution. Avoid or limit alcohol consumption along with Mirahype S 50/5 Tablet ER as it could lead to increased dizziness. Inform your doctor about your health condition and medications before taking Mirahype S 50/5 Tablet ER to rule out any side effects/interactions.
Uses of Mirahype S 50/5 Tablet ER
Medicinal Benefits
Mirahype S 50/5 Tablet ER is a combination of two drugs, namely: Solifenacin and Mirabegron. Mirahype S 50/5 Tablet ER is a combination medicine used to treat overactive bladder (OAB) with symptoms of urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, dysuria (painful or difficult urination). Solifenacin is an anti-cholinergic that reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. This decreases the urgency for urination. Mirabegron is a beta-3 adrenergic agonist which relaxes the muscles of the bladder; this prevents frequent, uncontrolled, or urgent urination. Together, Mirahype S 50/5 Tablet ER helps in treating an overactive bladder.
Directions for Use
Side Effects of Mirahype S 50/5 Tablet ER
Drug Warnings
Do not take Mirahype S 50/5 Tablet ER if you are allergic to any of its contents. Inform your doctor if you have glaucoma, myasthenia gravis, ulcerative colitis, urinary retention, high blood pressure, angioedema, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Mirahype S 50/5 Tablet ER is not recommended for children. Mirahype S 50/5 Tablet ER may cause blurred vision, so drive with caution. Avoid or limit alcohol consumption with Mirahype S 50/5 Tablet ER as it could lead to increased dizziness.
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
by Others
by Others
by Others
by Others
by Others